Elevate Your Investing Strategy:
- Take advantage of TipRanks Premium at 50% off! Unlock powerful investing tools, advanced data, and expert analyst insights to help you invest with confidence.
Materialise ( (MTLS) ) has issued an update.
On October 28, 2025, Materialise NV reported its financial results for the third quarter of 2025, highlighting a 2.2% increase in total consolidated revenue compared to the previous quarter, though a 3.5% decrease from the same period in 2024. The Materialise Medical segment achieved a record quarterly revenue growth of 10.3% year-over-year, despite macroeconomic challenges impacting overall revenue, particularly in the Manufacturing segment. The company maintained strong cash flow and a positive net result, with a net profit of 1,848 kEUR. CEO Brigitte de Vet-Veithen emphasized the company’s focus on cost control and continued R&D investments to ensure future growth, while acknowledging ongoing geopolitical and economic uncertainties.
The most recent analyst rating on (MTLS) stock is a Hold with a $6.50 price target. To see the full list of analyst forecasts on Materialise stock, see the MTLS Stock Forecast page.
Spark’s Take on MTLS Stock
According to Spark, TipRanks’ AI Analyst, MTLS is a Neutral.
Materialise’s overall score reflects stable financial performance with low leverage but challenges in revenue growth and cash flow. Positive technical indicators and strategic growth in the Medical segment are offset by valuation concerns and mixed earnings sentiment.
To see Spark’s full report on MTLS stock, click here.
More about Materialise
Materialise NV is a global leader in 3D-printed medical devices and software, and a pioneer in additive manufacturing software and services. The company focuses on providing innovative solutions in the medical and manufacturing sectors, leveraging its expertise in 3D printing technology.
Average Trading Volume: 141,494
Technical Sentiment Signal: Buy
Current Market Cap: $356.8M
See more insights into MTLS stock on TipRanks’ Stock Analysis page.

